Bionomics Free Cash Flow Yield vs Cash Ratio Analysis

BNOX Stock

USD 0.28 0.01 3.45%

Bionomics financial indicator trend analysis is way more than just evaluating Bionomics ADR prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bionomics ADR is a good investment. Please check the relationship between Bionomics Free Cash Flow Yield and its Cash Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Free Cash Flow Yield vs Cash Ratio

Free Cash Flow Yield vs Cash Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bionomics ADR Free Cash Flow Yield account and Cash Ratio. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Bionomics' Free Cash Flow Yield and Cash Ratio is 0.11. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Cash Ratio in the same time period over historical financial statements of Bionomics Ltd ADR, assuming nothing else is changed. The correlation between historical values of Bionomics' Free Cash Flow Yield and Cash Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Bionomics Ltd ADR are associated (or correlated) with its Cash Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Ratio has no effect on the direction of Free Cash Flow Yield i.e., Bionomics' Free Cash Flow Yield and Cash Ratio go up and down completely randomly.

Correlation Coefficient

0.11

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Cash Ratio

Most indicators from Bionomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bionomics ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

At this time, Bionomics' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 17 M in 2024, whereas Tax Provision is likely to drop (91.7 K) in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	26.9K	21.3K	20K	19K
Depreciation And Amortization	804.5K	778.2K	434.4K	412.7K

Interest Expense Depreciation And Amortization

Bionomics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Liab	Property Plant And Equipment Net	Non Current Assets Total	Net Receivables	Inventory	Intangible Assets	Current Deferred Revenue	Good Will	Short Term Investments	Non Currrent Assets Other
Total Assets		0.52	0.75	0.75	-0.47	-0.01	0.63	0.8	0.8	-0.16	0.75	0.8	0.73	0.97	0.4	0.25	0.58	0.66	0.9	0.37	0.23	0.87	0.27	0.63	0.84	-0.2
Short Long Term Debt Total	0.52		0.81	-0.13	0.26	0.18	0.24	0.45	0.46	-0.42	0.67	0.76	0.93	0.45	0.88	-0.23	0.85	0.89	0.57	-0.2	0.34	0.44	-0.38	0.49	0.54	-0.57
Total Current Liabilities	0.75	0.81		0.2	0.14	0.11	0.61	0.44	0.44	-0.36	0.84	0.9	0.94	0.66	0.8	-0.06	0.73	0.87	0.81	0.19	0.2	0.75	0.0	0.54	0.72	-0.16
Total Stockholder Equity	0.75	-0.13	0.2		-0.8	-0.08	0.45	0.65	0.65	0.06	0.29	0.34	0.1	0.79	-0.19	0.41	0.03	0.11	0.58	0.51	0.15	0.63	0.55	0.35	0.49	0.08
Net Debt	-0.47	0.26	0.14	-0.8		0.18	-0.25	-0.74	-0.74	-0.26	-0.02	-0.01	0.12	-0.58	0.38	-0.44	0.05	0.06	-0.2	-0.04	0.06	-0.23	-0.42	-0.1	-0.2	-0.07
Retained Earnings	-0.01	0.18	0.11	-0.08	0.18		0.0	-0.06	-0.06	-0.92	-0.01	0.36	0.07	0.08	0.16	-0.94	0.07	0.28	-0.18	0.16	0.71	0.04	0.12	-0.54	-0.25	0.09
Accounts Payable	0.63	0.24	0.61	0.45	-0.25	0.0		0.4	0.41	-0.11	0.73	0.59	0.48	0.57	0.14	0.14	0.24	0.51	0.65	0.22	-0.04	0.73	0.13	0.22	0.58	0.42
Cash	0.8	0.45	0.44	0.65	-0.74	-0.06	0.4		1.0	-0.04	0.49	0.53	0.53	0.85	0.25	0.25	0.54	0.56	0.58	-0.11	0.16	0.51	0.12	0.43	0.56	-0.33
Cash And Short Term Investments	0.8	0.46	0.44	0.65	-0.74	-0.06	0.41	1.0		-0.04	0.5	0.53	0.53	0.85	0.26	0.25	0.54	0.57	0.59	-0.11	0.16	0.52	0.13	0.43	0.56	-0.32
Common Stock Shares Outstanding	-0.16	-0.42	-0.36	0.06	-0.26	-0.92	-0.11	-0.04	-0.04		-0.16	-0.57	-0.3	-0.19	-0.42	0.86	-0.29	-0.49	-0.07	-0.12	-0.77	-0.24	0.04	0.29	0.04	0.08
Non Current Liabilities Total	0.75	0.67	0.84	0.29	-0.02	-0.01	0.73	0.49	0.5	-0.16		0.71	0.83	0.65	0.52	0.09	0.51	0.84	0.83	0.17	0.07	0.76	0.05	0.6	0.74	-0.02
Other Current Assets	0.8	0.76	0.9	0.34	-0.01	0.36	0.59	0.53	0.53	-0.57	0.71		0.86	0.75	0.67	-0.23	0.7	0.81	0.76	0.26	0.44	0.8	0.07	0.36	0.71	-0.23
Total Liab	0.73	0.93	0.94	0.1	0.12	0.07	0.48	0.53	0.53	-0.3	0.83	0.86		0.65	0.8	-0.05	0.85	0.89	0.76	0.04	0.18	0.66	-0.16	0.59	0.76	-0.39
Total Current Assets	0.97	0.45	0.66	0.79	-0.58	0.08	0.57	0.85	0.85	-0.19	0.65	0.75	0.65		0.29	0.17	0.55	0.6	0.77	0.39	0.24	0.76	0.36	0.51	0.73	-0.17
Short Term Debt	0.4	0.88	0.8	-0.19	0.38	0.16	0.14	0.25	0.26	-0.42	0.52	0.67	0.8	0.29		-0.23	0.75	0.79	0.51	-0.17	0.32	0.4	-0.33	0.44	0.43	-0.46
Common Stock	0.25	-0.23	-0.06	0.41	-0.44	-0.94	0.14	0.25	0.25	0.86	0.09	-0.23	-0.05	0.17	-0.23		-0.09	-0.24	0.35	0.03	-0.58	0.17	0.07	0.59	0.37	-0.04
Other Current Liab	0.58	0.85	0.73	0.03	0.05	0.07	0.24	0.54	0.54	-0.29	0.51	0.7	0.85	0.55	0.75	-0.09		0.67	0.55	-0.1	0.19	0.44	-0.37	0.47	0.62	-0.56
Property Plant And Equipment Net	0.66	0.89	0.87	0.11	0.06	0.28	0.51	0.56	0.57	-0.49	0.84	0.81	0.89	0.6	0.79	-0.24	0.67		0.68	-0.08	0.4	0.6	-0.11	0.44	0.54	-0.27
Non Current Assets Total	0.9	0.57	0.81	0.58	-0.2	-0.18	0.65	0.58	0.59	-0.07	0.83	0.76	0.76	0.77	0.51	0.35	0.55	0.68		0.3	0.15	0.94	0.08	0.76	0.91	-0.19
Net Receivables	0.37	-0.2	0.19	0.51	-0.04	0.16	0.22	-0.11	-0.11	-0.12	0.17	0.26	0.04	0.39	-0.17	0.03	-0.1	-0.08	0.3		0.15	0.37	0.58	0.22	0.26	0.23
Inventory	0.23	0.34	0.2	0.15	0.06	0.71	-0.04	0.16	0.16	-0.77	0.07	0.44	0.18	0.24	0.32	-0.58	0.19	0.4	0.15	0.15		0.23	-0.07	-0.02	-0.01	-0.4
Intangible Assets	0.87	0.44	0.75	0.63	-0.23	0.04	0.73	0.51	0.52	-0.24	0.76	0.8	0.66	0.76	0.4	0.17	0.44	0.6	0.94	0.37	0.23		0.18	0.5	0.87	-0.01
Current Deferred Revenue	0.27	-0.38	0.0	0.55	-0.42	0.12	0.13	0.12	0.13	0.04	0.05	0.07	-0.16	0.36	-0.33	0.07	-0.37	-0.11	0.08	0.58	-0.07	0.18		-0.07	0.03	0.45
Good Will	0.63	0.49	0.54	0.35	-0.1	-0.54	0.22	0.43	0.43	0.29	0.6	0.36	0.59	0.51	0.44	0.59	0.47	0.44	0.76	0.22	-0.02	0.5	-0.07		0.68	-0.5
Short Term Investments	0.84	0.54	0.72	0.49	-0.2	-0.25	0.58	0.56	0.56	0.04	0.74	0.71	0.76	0.73	0.43	0.37	0.62	0.54	0.91	0.26	-0.01	0.87	0.03	0.68		-0.26
Non Currrent Assets Other	-0.2	-0.57	-0.16	0.08	-0.07	0.09	0.42	-0.33	-0.32	0.08	-0.02	-0.23	-0.39	-0.17	-0.46	-0.04	-0.56	-0.27	-0.19	0.23	-0.4	-0.01	0.45	-0.5	-0.26

Click cells to compare fundamentals

Bionomics Account Relationship Matchups

Bionomics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	23.8M	40.7M	45.1M	28.6M	27.6M	35.9M
Short Long Term Debt Total	8.4M	651.5K	477.0K	355.2K	239.6K	227.6K
Total Current Liabilities	5.7M	1.8M	2.3M	2.8M	3.8M	4.9M
Total Stockholder Equity	8.8M	35.7M	39.3M	22.1M	17.5M	22.6M
Net Debt	5.3M	(20.7M)	(22.7M)	(11.8M)	(12.4M)	(13.0M)
Retained Earnings	(102.8M)	(115.5M)	(119.7M)	(136.4M)	(178.0M)	(169.1M)
Accounts Payable	870.6K	772.9K	1.1M	1.4M	2.2M	1.6M
Cash	3.2M	21.4M	23.2M	12.2M	12.6M	14.2M
Cash And Short Term Investments	3.2M	21.4M	23.2M	12.2M	12.6M	14.2M
Common Stock Shares Outstanding	3.0M	4.3M	7.5M	8.2M	10.0M	10.5M
Liabilities And Stockholders Equity	23.7M	40.7M	44.9M	28.6M	27.6M	35.9M
Non Current Liabilities Total	4.3M	3.2M	3.5M	3.8M	6.3M	6.0M
Other Current Assets	2.6M	974.1K	1.0M	797.5K	458.8K	435.8K
Total Liab	15.0M	5.0M	5.8M	6.6M	10.2M	13.3M
Total Current Assets	5.8M	23.2M	28.9M	13.4M	13.2M	19.7M
Short Term Debt	4.1M	130.9K	110.1K	113.9K	155.1K	147.4K
Common Stock	102.2M	142.6M	150.3M	148.8M	171.1M	179.7M
Other Current Liab	4.8M	866.2K	1.1M	1.2M	1.4M	2.5M
Property Plant And Equipment Net	728.1K	653.1K	465.7K	334.5K	219.0K	208.0K
Non Current Assets Total	17.7M	17.4M	16.1M	15.2M	14.5M	16.8M
Net Receivables	12.1K	849.9K	4.7M	426.1K	84.7K	80.5K
Inventory	1.13	1.0	(4.7M)	(427.8K)	(458.3M)	(435.4M)
Intangible Assets	8.1M	7.5M	6.8M	6.1M	5.5M	7.1M
Current Deferred Revenue	(4.1M)	(130.8K)	(110.1K)	(114.4K)	(33.1K)	(34.8K)
Good Will	8.9M	9.3M	8.9M	8.7M	8.7M	7.6M
Accumulated Other Comprehensive Income	9.2M	8.6M	8.6M	9.7M	(3.0M)	(2.9M)
Non Currrent Assets Other	(17.7M)	(17.4M)	(16.1M)	(15.2M)	26.2K	27.5K
Other Assets	301.0K	89.2K	82.2K	79.3K	91.2K	152.0K
Other Stockholder Equity	21.9K	(32.5K)	(31.4K)	1.0	198.5M	208.4M
Other Liab	7.2M	3.6M	4.5M	5.4M	4.8M	7.1M
Net Tangible Assets	(12.0M)	25.3M	34.2M	10.9M	12.5M	7.4M
Net Invested Capital	24.1M	47.6M	56.9M	33.1M	17.5M	28.9M
Non Current Liabilities Other	5.0M	1.8M	2.7M	3.7M	590.6K	561.1K
Net Working Capital	60.8K	28.6M	38.5M	16.0M	9.4M	8.9M
Property Plant Equipment	1.1M	870.9K	674.5K	502.3K	452.0K	429.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bionomics Free Cash Flow Yield vs Cash Ratio Analysis

Free Cash Flow Yield vs Cash Ratio

Free Cash Flow Yield vs Cash Ratio Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Cash Ratio

Bionomics fundamental ratios Correlations

Bionomics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bionomics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Bionomics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.97	Total Assets
Total Liab	+ 0.94	Total Current Liabilities
Intangible Assets	+ 0.94	Non Current Assets Total
Total Liab	+ 0.93	Short Long Term Debt Total
Short Term Investments	+ 0.91	Non Current Assets Total

Common Stock	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.92	Retained Earnings
Net Debt	- 0.8	Total Stockholder Equity
Inventory	- 0.77	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.74	Net Debt
Cash	- 0.74	Net Debt